Clinical Trials
14 trialsNCT06745583 2026-06-03
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
NCT07446842 2026-03-06
Construction of AI Model for Precision Imaging Diagnosis of Cranial Diseases
Tongji Hospital
Recruiting
NCT05522387 2026-02-27
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Inmune Bio, Inc.
Phase 2 Terminated
NCT06755840 2025-04-03
Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
Xiangya Hospital of Central South University
Recruiting
NCT06251830 2024-02-09
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
IRCCS Fondazione Stella Maris
Completed
NCT06211803 2024-01-18
JPETClinic
Jagiellonian University
Completed
NCT05321498 2023-09-28
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
Inmune Bio, Inc.
Phase 2 Withdrawn
NCT03336489 2018-12-07
DICODOM
Fondation Ophtalmologique Adolphe de Rothschild
Completed
NCT03426488 2018-02-08
NSHDS
Umeå University
Unknown
NCT02452216 2017-08-31
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
Stanford University
Phase EARLY_PHASE1 Completed
NCT03242109 2017-08-08
The Moli-sani Study
Neuromed IRCCS
Completed
NCT01969370 2017-05-03
NCGENES
University of North Carolina, Chapel Hill
Phase NA Completed
NCT02108769 2014-04-09
Yogic Breathing Changes Salivary Components
Medical University of South Carolina
Phase NA Completed
NCT00643890 2012-02-22
Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease
Neurologix, Inc.
Phase 2 Terminated